Cognition Therapeutics, Inc. (CGTX) vs Conexeu Sciences Inc. (CNXU)

A side-by-side comparison of Cognition Therapeutics, Inc. and Conexeu Sciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CGTX

Cognition Therapeutics, Inc.

$84M

$0.94HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

CNXU

Conexeu Sciences Inc.

$83M

$3.12HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — CGTX vs CNXU

growth of $100 · dividends reinvested · last 1y

CGTX -25.0% (-25.0%/yr)CNXU -76.1% (-76.1%/yr)CGTX compounded faster over this window

CGTX CNXU

Metrics side by side

Total return (annualized)

Metric	CGTX	CNXU
Total return (1Y)	-39.33%	N/A
Total return CAGR (3Y)	-10.76%	N/A

CNXU is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full CGTX analysis Full CNXU analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.